信息搜索
信息关键字：药
  

共有4382条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]

·贵州百灵突围中小板 苗药龙头拉开整合序幕2011-5-22 10:41:31
·主营收入猛增毛利率奇低 华北制药被疑隐藏利润2011-5-22 10:33:09
·蜀中制药因造假被停产折射中药企业困境2011-5-21 14:55:06
·尼美舒利12岁以下禁服 康芝药业受冲击(图)2011-5-21 11:26:49
·国家药监局下发通知：12岁以下儿童禁用尼美舒利2011-5-21 3:05:13
·西南药业股东太极集团减持1%股份2011-5-20 19:55:43
·振东制药：扩张之路再迈一步 产品又添新亮点2011-5-20 18:56:55
·益佰制药：调整完成 步入快速发展时期2011-5-20 18:19:19
·振东制药：产品储备丰富的中药特色企业2011-5-20 18:11:00
·江苏吴中：医药和地产共成长 新药是亮点2011-5-20 18:06:45
·振东制药：收购安特制药 打造下一个泰盛2011-5-20 17:16:40
·华东医药：工商业发展稳健 长期趋势向好2011-5-20 17:04:07
·江苏吴中：医药和地产共成长 新药是亮点2011-5-20 16:59:54
·江苏吴中：医药和地产共成长 新药是亮点2011-5-20 15:28:06
·振东制药：收购安特制药 打造下一个泰盛2011-5-20 15:03:08
·誉衡药业被责令整改机构昨抛售2696万元2011-5-20 11:22:19
·双鹭药业：股权激励行权完毕 看好公司长期发展2011-5-20 11:21:41
·5个月狂跌50% 康芝药业成创业板“第一熊股”2011-5-20 10:52:44
·誉衡药业被责令整改 机构昨抛售2696万元2011-5-20 10:40:13
·齐鲁证券：维持振东制药“买入”评级2011-5-20 9:42:08

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]